A 12-Month Observational Study Evaluating the Glycaemic Control in Subjects Using NovoMix 50 (Biphasic Insulin Aspart 50) for Treatment of Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 12 May 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.
- 12 May 2010 Actual patient number (269) added as reported by ClinicalTrials.gov.